Cargando…
Central Nervous System Prophylaxis and Treatment in Acute Leukemias
Improvements in systemic therapy in the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and reduced the incidence of CNS relapse. However, management of patients with CNS disease remains challenging, and relapses in the CNS can be diffi...
Autores principales: | Wu, Susan Y., Short, Nicholas J., Nasr, Lewis, Dabaja, Bouthaina S., Fang, Penny Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767998/ https://www.ncbi.nlm.nih.gov/pubmed/36510037 http://dx.doi.org/10.1007/s11864-022-01032-5 |
Ejemplares similares
-
Treatment of Relapsed Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2020) -
Can Immune Therapy Cure Acute Myeloid Leukemia?
por: Gale, Robert Peter
Publicado: (2023) -
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia
por: Rüchel, Nadine, et al.
Publicado: (2022) -
When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
por: Laneuville, Pierre
Publicado: (2018) -
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
por: Cao, Xinping, et al.
Publicado: (2023)